ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
5.55
-0.03 (-0.54%)
Nov 22, 2024, 4:00 PM EST - Market closed
ReShape Lifesciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 5 | 3 | 29 | 20 | 2 | |
| Market Cap Growth | -32.53% | 41.89% | -88.83% | 47.08% | 882.72% | 8.27% | |
| Enterprise Value | 2 | 3 | -3 | 3 | 28 | -5 | |
| Last Close Price | 5.55 | 14.48 | 390.92 | 4755.99 | 10294.99 | 16674.98 | |
| PS Ratio | 0.27 | 0.53 | 0.29 | 2.14 | 1.75 | 0.13 | |
| PB Ratio | 2.63 | 0.69 | 0.89 | 0.66 | 1.37 | 0.08 | |
| P/TBV Ratio | 1.93 | 0.69 | 0.96 | 1.24 | - | - | |
| EV/Sales Ratio | 0.28 | 0.40 | - | 0.25 | 2.50 | - | |
| Debt / Equity Ratio | 0.13 | 0.04 | 0.05 | 0.01 | 0.91 | 0.22 | |
| Asset Turnover | 1.22 | 0.80 | 0.35 | 0.30 | 0.29 | 0.35 | |
| Inventory Turnover | 0.85 | 0.85 | 1.34 | 2.00 | 2.83 | 5.03 | |
| Quick Ratio | 0.52 | 1.62 | 0.81 | 3.40 | 0.48 | 0.68 | |
| Current Ratio | 1.33 | 2.73 | 1.32 | 3.98 | 0.77 | 0.97 | |
| Return on Equity (ROE) | -309.28% | -220.59% | -192.58% | -214.70% | -112.09% | -266.12% | |
| Return on Assets (ROA) | -73.66% | -83.92% | -53.16% | -34.82% | -20.30% | -23.11% | |
| Return on Capital (ROIC) | -196.22% | -170.11% | -69.87% | -43.11% | -27.20% | -32.46% | |
| Earnings Yield | -251.31% | -246.26% | -1418.17% | -216.52% | -109.09% | -3677.85% | |
| FCF Yield | -367.72% | -676.13% | -53.93% | -45.09% | -704.47% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.